Intervacc announced that Strangvac, a vaccine against the highly contagious infectious disease equine strangles, has been released for sale in Denmark.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.145 SEK | +2.09% | -1.08% | -34.60% |
Mar. 04 | Intervacc AB Announces Changes in the Nomination Committee | CI |
Feb. 28 | Intervacc's Acting CEO Assumes Role Permanently | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.60% | 28.24M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.08% | 22.2B | |
-16.53% | 21.23B | |
-8.70% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- IVACC Stock
- News Intervacc AB
- Intervacc Announces Strangvac, A Vaccine Against Equine Strangles, Available for Sale in Denmark